166 related articles for article (PubMed ID: 15721445)
1. Prolonged survival following salvage surgery for chemorefractory ovarian immature teratoma: a case report and review of the literature.
Rezk Y; Sheinfeld J; Chi DS
Gynecol Oncol; 2005 Mar; 96(3):883-7. PubMed ID: 15721445
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
3. Salvage surgery for chemorefractory ovarian germ cell tumors.
Munkarah A; Gershenson DM; Levenback C; Silva EG; Messing MJ; Morris M; Burke TW
Gynecol Oncol; 1994 Nov; 55(2):217-23. PubMed ID: 7959287
[TBL] [Abstract][Full Text] [Related]
4. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer.
Munkarah AR; Coleman RL
Gynecol Oncol; 2004 Nov; 95(2):273-80. PubMed ID: 15491746
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
[TBL] [Abstract][Full Text] [Related]
6. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.
Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S
J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820
[TBL] [Abstract][Full Text] [Related]
7. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
8. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
9. Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort.
Reddihalli PV; Subbian A; Umadevi K; Rathod PS; Krishnappa S; Nanaiah SP; Bafna UD
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():17-21. PubMed ID: 26142911
[TBL] [Abstract][Full Text] [Related]
10. Experimental characterization of recurrent ovarian immature teratoma cells after optimal surgery.
Tanaka T; Toujima S; Utsunomiya T; Yukawa K; Umesaki N
Oncol Rep; 2008 Jul; 20(1):13-23. PubMed ID: 18575713
[TBL] [Abstract][Full Text] [Related]
11. The role of secondary cytoreductive surgery for recurrent ovarian cancer.
Güngör M; Ortaç F; Arvas M; Kösebay D; Sönmezer M; Köse K
Gynecol Oncol; 2005 Apr; 97(1):74-9. PubMed ID: 15790440
[TBL] [Abstract][Full Text] [Related]
12. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
[TBL] [Abstract][Full Text] [Related]
13. Germ cell tumors of the ovary.
Pectasides D; Pectasides E; Kassanos D
Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
[TBL] [Abstract][Full Text] [Related]
14. Recurrent immature teratoma of the ovary: a case report of radical secondary cytoreduction with replacement of the aortic bifurcation.
Wu X; Han LY; Xu X; Li Z
Gynecol Oncol; 2004 Dec; 95(3):746-9. PubMed ID: 15581997
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy following conservative surgery and adjunctive chemotherapy for stage III immature teratoma of the ovary.
Lee RB; Kelly J; Elg SA; Benson WL
Obstet Gynecol; 1989 May; 73(5 Pt 2):853-5. PubMed ID: 2704518
[TBL] [Abstract][Full Text] [Related]
16. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.
McCreath WA; Eisenhauer EL; Abu-Rustum NR; Venkatraman ES; Caceres A; Bier R; Huh J; Cho J; Barakat RR; Chi DS
Gynecol Oncol; 2006 Jul; 102(1):8-14. PubMed ID: 16427689
[TBL] [Abstract][Full Text] [Related]
17. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
18. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
19. The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Aghajanian C; Barakat RR; Chi DS
Gynecol Oncol; 2008 Feb; 108(2):276-81. PubMed ID: 18063020
[TBL] [Abstract][Full Text] [Related]
20. Salvage cytoreduction for chemorefractory ovarian cancer with peritoneal carcinomatosis: a last chance or futile efforts?
Chua TC; Robertson G; Liauw W; Morris DL
Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):478-84. PubMed ID: 21039384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
